21/02/2006
Stralfors has signed an agreement with Novo Nordisk regarding taking over their internal printing works for pharmaceutical information and packaging, situated on the outskirts of Copenhagen. The takeover, which will be on 31 March, will involve Stralfors taking over existing personnel, 36 employees, and machinery and stock. To start off with, production will continue in the same premises as before, but it is expected that it will be moved to new premises in the Copenhagen area at the end of 2006.
Stralfors has also signed a 5-year agreement with Novo Nordisk to print their leaflets, labels and packaging. The agreement involves annual sales of a minimum of 100 MDKK within the contract period.
The takeover of the Novo Nordisk printing works and the 5-year agreement are fully in line with Stralfors’ strategy of investing in niches within Business Area Graphics, for example, graphics products for the pharmaceuticals industry. The information material for the pharmaceuticals industry, in the form of leaflets, labels and small brochures, are products which involve very stringent safety requirements. Stralfors has broad experience of such production, and has adapted production processes to the high demands set by the pharmaceuticals industry. Additionally, Business Area Graphics has developed its own concept for rational, safe handling, including the use of electronic ordering systems.
Novo Nordisk is a global market leader within the area of insulin treatment, based in Denmark, and has sales of about MDKK 33 000. Together with AstraZeneca, the group is the largest user of printed secondary material in Scandinavia.
”We consider our opportunities of expanding within the product area of information material to the pharmaceuticals industry as very good”, says Ulf Sköld, Division Manager Graphic Solutions, Stralfors. ”We already have graphic production in Sweden, Norway, France and Great Britain. With the takeover of the printing works from Novo Nordisk and the signing of a 5-year agreement with them, we have taken a big step into the Danish market, and are strengthening our position and competitiveness yet further. We also see future coordination opportunities with Business Area Labels”.
”The reason that we chose to outsource our internal printing works to Stralfors is that we feel it to be a good possibility also being supplied in future with printed packaging material to competitive prices and to right quality. As graphic production does not belong to Novo Nordisk’ core business, Stralfors will be able to focus more on securing a future development, rather than we would", says Kim Tosti, Senior Vice President, Devices and Sourcing, Novo Nordisk.
For further information, please contact:
Ulf Sköld, Stralfors
Division Manager Graphic Solutions
Telephone: +46 (0)40-661 37 20
Mobile: +46 (0)70-958 66 15
Press contact, Stralfors:
Elisabeth Sjöberg
Information Officer
Telephone: +46 (0)372-851 19
Stralfors is an IT-focused Business-to-Business company with a print heritage providing total solutions within the field of information transfer. Stralfors develops, produces and delivers systems, services and products for the efficient communication of information crucial to operating a business. The Group has net sales of SEK 3.4 billion and operates in 12 countries with 2000 employees. Stralfors “B” shares have been quoted on the Stockholm Stock Exchange since 1984.